Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To estimate the difference in change in HbA1c from the randomization visit (visit 2) to endpoint (30 weeks) between 2 regimens: BET (basal insulin Glargine, Exenatide BID and metformin) and BBT (basal insulin Glargine, bolus insulin insulin TID and metformin) in subjects with type 2 diabetes and inadequate glycemic control (HbA1c > 7.0%) pretreated with basal insulin Glargine in combination with metformin or in combination with metformin and sulfonylurea (SU).
Critère d'inclusion
- diabetes